Similarly, exogenous administration of OMD protein solely was sufficient to activate SMCs into a synthetic phenotype, inducing endogenous OMD expression and ECM reorganisation, possibly via SMAD3 transcription factor, while generally preventing other changes in expression of SMC markers and markers of osteoblastic or inflammatory transition. Here, SMAD3 is linked to occult macular dystrophy.